By 2025, innovations such as lab-on-a-chip technology, automation, and CRISPR-Cas9 gene editing are expected to enhance ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...

Cystic fibrosis (CF) is a life-threatening genetic disease affecting multiple organ systems, with pancreatic dysfunction ...

Cystic fibrosis (CF) is a life-threatening genetic disease affecting multiple organ systems, with pancreatic dysfunction representing a critical and ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...

If we assume all patients who began treatment with Casgevy last year progress to the administration stage, CRISPR and Vertex ...

Technological advancements, particularly in gene editing techniques such as CRISPR-Cas9, have significantly enhanced the precision and efficiency of gene therapy approaches. Moreover, increased ...

The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...